Skip to main content
. Author manuscript; available in PMC: 2022 Jan 13.
Published in final edited form as: Mol Cancer Res. 2019 Mar 12;17(6):1365–1377. doi: 10.1158/1541-7786.MCR-18-0256

Figure 2. Kinetics of cell growth and metabolic changes upon IBR in various MCL cells.

Figure 2.

(A) Viable cell number. (B) Intracellular 1H MRS metabolite concentrations. (C) Cell cycle distribution. *, p<0.05; N.S., statistically not significant. All data were presented as mean±SD. In Fig 2A and 2B, gray bar = control; red bar = IBR-treated.